刘影;李月婷;查雨锋;王静娴;肖婷婷;李靖;董莉;傅晓钟;黄勇;王永林;
LIU Ying,LI Yueting,ZHA Yufeng,WANG Jingxian,XIAO Tingting,LI Jing, DONG Li,FU Xiaozhong,HUANG Yong,WANG Yonglin(School of Pharmacology,Guiyang Medical College,Guiyang 550004,Guizhou,China)

• 1:贵阳医学院药学院

摘要(Abstract)：

目的:建立人结肠腺癌细胞系(Caco-2)细胞模型并对其药物研究的方法进行初步探讨。方法:通过测定跨细胞膜电阻(TEER)、荧光素通透量及碱性磷酸酶(AKP)评价Caco-2细胞模型,用MTT法考察HBSS缓冲液在不同pH值、不同温度及不同时间条件下对Caco-2细胞的毒性。结果:各项指标的测定值符合要求,表明本实验建立的Caco-2细胞模型的完整性、紧密性和通透性良好;进行药物Caco-2细胞吸收潜性研究时,药物作用4 h之内对Caco-2细胞模型没有影响。结论:建立的Caco-2细胞模型可用于药物吸收机制研究。
Objective: To establish the Caco-2 cell model,and to explore the method for applying it in drug research.Methods: Transepithelial electrical resistance(TEER),the permeability of fluorescein and the expression of alkaline phosphatase(APK) were used to evaluate Caco-2 cell model.MTT method was used to detect the toxicity of HBSS buffer to Caco-2 cell on the condition of different pH,different temperature and cultivation time.Results: Test results of all the indexes met the requirements,which indicated that integrity,consistency and permeability of the established Caco-2 cell model were good.The model was not affected when Caco-2 cell was used in drug absorption study within 4 hours.Conclusions: The established Caco-2 cell model can be used to study the absorption mechanism of drugs.

关键词(KeyWords)： 结肠;腺癌;细胞,培养的;碱性磷酸酶;毒性试验
colon;adenocarcinoma;cells,cultured;alkaline phosphatase;toxicity tests

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(No.20962004,No.81060359);; 贵州省中药现代化科技产业研究开发专项[黔科合设字(2010)5019];; 贵州省社会发展攻关计划[黔科合SY(2010)3046号];; 贵州省科技厅攻关计划[黔科合GY字(2008)3028]

作者(Author): 刘影;李月婷;查雨锋;王静娴;肖婷婷;李靖;董莉;傅晓钟;黄勇;王永林;
LIU Ying,LI Yueting,ZHA Yufeng,WANG Jingxian,XIAO Tingting,LI Jing, DONG Li,FU Xiaozhong,HUANG Yong,WANG Yonglin(School of Pharmacology,Guiyang Medical College,Guiyang 550004,Guizhou,China)

Email:

DOI: 10.19367/j.cnki.1000-2707.2012.05.003

参考文献(References)：

• [1]蔡润兰,王敏,齐云,等.Caco-2细胞模型验证指标的选择与评判[J].中国药学杂志,2008(43):1871-1875.
• [2]鲁鑫焱,蒋惠娣,曾苏.黄铜类化合物在Caco-2细胞模型上的转运和代谢研究进展[J].中国药学杂志,2006(17):1289-1292.
• [3]郭涛.Caco-2细胞模型在药物动力学研究中的应用[J].中国药师,2003(12):774-776.
• [4]袁明勇,郑伶俐,陈静,等.Caco-2细胞模型在药物研究中的应用[J].中国药师,2009(7):969-971.
• [5]曾宝,王春玲,吴安国,等.Caco-2细胞模型的建立及其在中药吸收研究中的应用探讨[J].中药新药与临床药理,2010(21):570-573.
• [6]杨秀伟,杨晓达,王莹,等.中药化学成分肠吸收研究中Caco-2细胞模型和标准操作规程的建立[J].中西医结合学报,2007(6):634-641.
• [7]齐云,王敏,蔡润兰.Caco-2细胞模型在口服药物转运机制研究中应用的进展[J].中国药学杂志,2009(17):1281-1284.
• [8]王敏,齐云.Caco-2细胞模型及其在药物吸收研究中的应用新进展[J],中国药学杂志,2007(16):1201-1204.
• [9]Zhenting Yuana,Haiyan Xu,Ke Wanga.Determinationof osthol and its metabolites in a phase I reaction systemand the Caco-2 cell model by HPLC-UV and LC-MS/MS[J].Journal of Pharmaceutical and Biomedical Analysis,2009(49):1226-1232.
• [10]Yongbing Sun,Jin Sun,Shiliang Shi.Synthesis,trans-port and pharmacokinetics of 5#-amino acid ester pro-drugs of 1-#-d-arabinofuranosylcytosine[J].MolecularPharmaceutics,2009(1):1021-1031.
• [11]Yasuhiro Tsume,John M,Hilfinger,et al.Amidon,en-hanced cancer cell growth inhibition by dipeptide pro-drugs of floxuridine:increased transporter affinity andmetabolic stability[J].Molecular Pharmaceutics,2008(5):717-727.

文章评论(Comment)：